» Articles » PMID: 11075301

Premature Ovarian Failure: Etiology and Prospects

Overview
Publisher Informa Healthcare
Date 2000 Nov 15
PMID 11075301
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

A search of past and current articles on ovarian physiology and premature ovarian failure (POF) using MEDLINE was performed in order to present an overview of clinical manifestations, necessary laboratory investigations, possible etiologies and treatments for POF. POF is defined as gonadal failure before the age of 40 years. Initially, POF was thought to be permanent, but it is now believed that spontaneous remissions and even pregnancies are possible in affected women. In most cases, the etiology of POF remains elusive, but several rare specific causes have been identified. Although the etiology of POF is heterogenic, the treatment principles are the same. Hormone replacement therapy (HRT) is still the cornerstone of treatment. The only proven method of obtaining a pregnancy in patients with POF is fertilization of a donor oocyte. Cryopreservation of oocytes has worked well in animals but awaits refinement before it can be applied routinely to humans with prodromal POF, or to patients before chemotherapy or irradiation in order to save their oocytes for future fertilization. New alternatives to traditional HRT and methods of fertility preservation are under development, but understanding of the basic pathophysiology of POF is necessary for the development and use of innovative treatments.

Citing Articles

Chaihu Shugan San and Zuogui Yin synergistically improve premature ovarian failure in a rat model via the PI3K/Akt/mTOR pathway.

Zhang F, Liu R, Xu Z, Chen W, Lu X, Wang Y Transl Oncol. 2025; 53:102298.

PMID: 39933394 PMC: 11869595. DOI: 10.1016/j.tranon.2025.102298.


Single-Cell RNA Sequencing Reveals That C5AR1 in Follicle Monocyte Cells Could Predict the Development of POI.

Han Y, Diao J, Wang X, Zhang S, Yuan L, Ping Y J Inflamm Res. 2024; 17:11221-11234.

PMID: 39717665 PMC: 11664250. DOI: 10.2147/JIR.S490996.


Novel Advances in Cell-Free Therapy for Premature Ovarian Failure (POF): A Comprehensive Review.

Yahyavi Y, Kheradi N, Karimi A, Ebrahimi-Kalan A, Ramezani F, Yousefi S Adv Pharm Bull. 2024; 14(3):543-557.

PMID: 39494249 PMC: 11530876. DOI: 10.34172/apb.2024.059.


Stem cell therapy for premature ovarian insufficiency: a systematic review and meta-analysis of animal and clinical studies.

Hu L, Tan R, He Y, Wang H, Pu D, Wu J Arch Gynecol Obstet. 2023; 309(2):457-467.

PMID: 37264272 DOI: 10.1007/s00404-023-07062-0.


Effects of low intensity pulsed ultrasound on expression of B-cell lymphoma-2 and BCL2-Associated X in premature ovarian failure mice induced by 4-vinylcyclohexene diepoxide.

Xu H, Xia Y, Qin J, Xu J, Li C, Wang Y Reprod Biol Endocrinol. 2021; 19(1):113.

PMID: 34284777 PMC: 8290625. DOI: 10.1186/s12958-021-00799-w.